Product Information
TESTIM 1% (50 MG) GEL is a brand product labeled by Endo USA Inc., priced at $3.7847 per GM under NDC 66887000105. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 31, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the testosterone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/5g
Manufacturer
Endo USA Inc.NDC
66887000105
Classification
Brand
Dosage Form
GEL
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
New Drug (NDA)
FDA Application
NDA021454FDA Approved
10/31/2002
TE Code
AB2
On Market Since
10/31/2002
Pharmacological Classes
Price Statistics
The NADAC for TESTIM 1% (50 MG) GEL has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 67.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7847 per GM |
|---|---|
| All-time high | $3.8135 (Apr 13, 2022) |
| All-time low | $2.2643 (Nov 28, 2013) |
| 52-week high | $3.7847 |
| 52-week low | $3.7751 |
| Median price | $3.7778 |
| Average price | $3.5331 |
| Largest weekly change | +10.0% (Jan 13, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the testosterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTIM 1% (50 MG) GEL?
The current National Average Drug Acquisition Cost (NADAC) for TESTIM 1% (50 MG) GEL, manufactured by Endo USA Inc., is $3.7847 per GM (NDC 66887000105), effective Sep 30, 2026.
How has the price of TESTIM 1% (50 MG) GEL changed over time?
Over the history we have for it, the NADAC for TESTIM 1% (50 MG) GEL has risen 67.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TESTIM 1% (50 MG) GEL?
Since Nov 28, 2013, the NADAC for TESTIM 1% (50 MG) GEL has ranged from a low of $2.2643 (Nov 28, 2013) to a high of $3.8135 (Apr 13, 2022), with a median of $3.7778 per GM.
Are there cheaper alternatives to TESTIM 1% (50 MG) GEL?
No other NADAC-published product currently shares the active ingredient and strength of TESTIM 1% (50 MG) GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TESTIM 1% (50 MG) GEL?
TESTIM 1% (50 MG) GEL (NDC 66887000105) is labeled by Endo USA Inc., and CMS classifies it as a brand product.